SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001104659-23-093288
Filing Date
2023-08-18
Accepted
2023-08-18 09:28:59
Documents
3
Period of Report
2023-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A tm2322255d3_6ka.htm 6-K/A 12673
2 EXHIBIT 99.1 tm2322255d3_ex99-1.htm EX-99.1 26274
3 GRAPHIC tm2322255d3_ex99-1img001.jpg GRAPHIC 87621
  Complete submission text file 0001104659-23-093288.txt   160758
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-39950 | Film No.: 231183926
SIC: 2836 Biological Products, (No Diagnostic Substances)